Your privacy

We use some essential cookies to make this website work. These cookies are used to improve your website experience. To find out more about the cookies we use, see our Privacy Policy.

We’d also like to use analytics cookies so we can understand how you use the service and make improvements.

Manage cookies

Use these toggles to accept or reject individual cookies. To find out more about the cookies we use, see our Privacy Policy.

Strictly Necessary Cookies

Disabling these cookies may degrade your web experience.

Functionality Cookies

Targeting/Advertising Cookies

In the Press

Regulating complexity in AI-enabled omics and multi-omics technologies for precision medicine

Read more

‘Going into industry’ is still a dirty phrase for academia. We need to change this.

Read more

Bayesian Digital Twins Show Potential For Predicting Prognosis And Treatment Response

Read more

How Bayesian-inspired uncertainty management could shape the future of trustworthy AI

Read more

Artificial intelligence’s role in cancer diagnosis

Read more

Concr completes clinical trial validating Bayesian AI for predicting response in breast cancer

Read more

Benefits of Strong, Ethical Data Handling

Read more

From Dark Matter to Digital Twins: How Concr is Revolutionising Cancer Treatment Prediction

Read more

The Dark Matter of Oncology: Mapping the invisible to make cancer predictable

Read more
Next Page

Careers

Help us enable biopharma, diagnostics and healthcare industries to discover better ways to overcome cancer.

Career opportunities

Partnerships

Our partners leverage Concr advanced predictive modelling across every stage of therapeutic development to create shared value for the benefit of cancer patients.

Partnerships

Investors

Our growth is powered by funding and hands-on support from across three continents.

Investors and funding